(3E,5E)-3-(3-pyridylmethylene)-5-(2-trifluoromethylbenzylidene)-1-((4-trifluoromethylphenyl)sulfonyl)piperidin-4-one

ID: ALA4555038

PubChem CID: 155556055

Max Phase: Preclinical

Molecular Formula: C26H18F6N2O3S

Molecular Weight: 552.50

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C1/C(=C/c2cccnc2)CN(S(=O)(=O)c2ccc(C(F)(F)F)cc2)C/C1=C\c1ccccc1C(F)(F)F

Standard InChI:  InChI=1S/C26H18F6N2O3S/c27-25(28,29)21-7-9-22(10-8-21)38(36,37)34-15-19(12-17-4-3-11-33-14-17)24(35)20(16-34)13-18-5-1-2-6-23(18)26(30,31)32/h1-14H,15-16H2/b19-12+,20-13+

Standard InChI Key:  WYKUYRINMBDPKK-KVOOEGMKSA-N

Molfile:  

 
     RDKit          2D

 38 41  0  0  0  0  0  0  0  0999 V2000
   38.9569   -4.4780    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.1397   -4.4780    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   38.5483   -5.1858    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.6054   -2.4515    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.6042   -3.2711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3123   -3.6800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0220   -3.2706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0191   -2.4479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3105   -2.0427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7253   -2.0367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4345   -2.4426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4350   -3.2570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1402   -3.6629    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.8488   -3.2551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8477   -2.4369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1380   -2.0266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1339   -1.2094    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.5552   -2.0281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2631   -2.4364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2587   -3.2533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9657   -3.6616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6742   -3.2527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6713   -2.4313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9637   -2.0267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9597   -1.2095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4325   -4.8886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7283   -4.4758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0210   -4.8837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0206   -5.7018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7333   -6.1102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4376   -5.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3134   -6.1113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6052   -5.7037    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   35.3145   -6.9285    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   34.6027   -6.5128    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   41.6654   -0.7975    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   40.2500   -0.8044    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   40.9545   -0.3921    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 15 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 24 25  1  0
 13  2  1  0
  2 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
 29 32  1  0
 32 33  1  0
 32 34  1  0
 32 35  1  0
 25 36  1  0
 25 37  1  0
 25 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4555038

    ---

Associated Targets(Human)

SMMC-7721 (5516 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
QGY-7703 (248 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L02 (4864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RELA Tchem Nuclear factor NF-kappa-B p65 subunit (627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nfkbia NF-kappa-B inhibitor alpha (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rela Transcription factor p65 (175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 552.50Molecular Weight (Monoisotopic): 552.0942AlogP: 5.86#Rotatable Bonds: 4
Polar Surface Area: 67.34Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 4.82CX LogP: 5.66CX LogD: 5.66
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.30Np Likeness Score: -1.21

References

1. Yao BR, Sun Y, Chen SL, Suo HD, Zhang YL, Wei H, Wang CH, Zhao F, Cong W, Xin WY, Hou GG..  (2019)  Dissymmetric pyridyl-substituted 3,5-bis(arylidene)-4-piperidones as anti-hepatoma agents by inhibiting NF-κB pathway activation.,  167  [PMID:30771605] [10.1016/j.ejmech.2019.02.020]

Source